Asepticys' Series B Round

Asepticys raised a round of funding on October 11, 2017. Investors include Eshelman Ventures.

Asepticys is a development stage company focused on developing new generation chemically-unique medical disinfection solutions effective against a broad spectrum of microbial pathogens that are clinic…

Articles about Asepticys' Series B Round: